ArticleThe international journal of neuropsychopharmacology2020

Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report.

Antoine Yrondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.